A drug company refuses to give a dying 7-year-old boy experimental medication because doing so would cut into its profits.
Cancer survivor Josh Hardy is fighting a viral infection he developed after a recent bone-marrow transplant, and his family has turned to social media to pressure pharmaceutical maker Chimerix into providing the antiviral drug brincidofovir.
The North Carolina-based company has already turned down multiple requests by Josh’s doctors for the unapproved drug, and it has so far remained unmoved by thousands of requests made by friends, family members, and other supporters.
“Our son will die without this drug,” said the boy’s father, Todd Hardy. “We’re begging them to give it to us.”
But the company’s CEO, Kenneth Moch, said Chimerix cannot agree to provide the drug for compassionate use because it would then be obligated to share the drug with other patients – and he said that would be too costly.